Back to top

View the PFP Archive

ZACKS
The End is Nigh?

The lead story in the Wall Street Journal on Monday was that individual investors are finally getting on board this bull market en masse. And as most everyone knows, this has proven to be a contrarian indicator.

Meaning that the average individual investor has a terrible habit of hopping on bull markets just before they reach their zenith and head crashing back down.

So should we be worried about this?

Right now this is good news as extra cash comes off the sidelines to bid up stocks. Typically this phase of the bull cycle is good for an extra 10-20% boost. However, 6-12 months down the road history probably may repeat itself with this being a signal that the bull market has run its course.

For now, this is just putting more logs on an already brightly burning fire.

Featured Commentaries:

•  Roundtable Top Picks for the Week of November 11th

•  3 Retail Winners for This Holiday Season

•  Global X Debuts New Emerging Market ETF

•  Technology Stock Roundup: CSCO/MSFT Steal The Show

Best,

Steve Reitmeister (aka Reity...pronounced "Righty")

Executive Vice President

Zacks Investment Research

Follow Us:  

Please login to Zacks.com or register to post a comment.

Sponsor

Exclusive Limited Time Offer - 20% OFF
options-trading-system.com

Signals are autotraded by Tradeking, Global Autotrading and Thinkorswim (TD Ameritrade).

Use QMT220 as a promo code to get 20% discount or click HERE

Bull & Bear of the Day

Zacks Rank #1

Tower International (TOWR)

With strong earnings momentum and attractive valuation, this Tower can still go a lot higher.

 

Zacks Rank #5

Polypore (PPO)

Investors should consider avoiding this stock until its earnings momentum turns around.


Stock Picking Strategies

Zacks Market Strategy: Shifting Sands  ››

3 Superstar Spin-off IPOs  ››

December Taper or Not?  ››


Funds Commentary

Zacks #1 Ranked Precious Metals Funds  ››

Is GRID a Better Utility ETF Choice?  ››

A Comprehensive Guide to REIT ETFs  ››


Options Strategies

Profiting from an Iron Condor in an Uncertain Market  ››


Video Reports

Roundtable Top Picks for the Week of Nov. 11th

Ideas for Medical, Entertainment and Drugs. Stocks covered include McKesson Corp. (MCK), Netflix (NFLX) and Pharmacyclics (PCYC).

This Week's Growth & Income Stocks: (MAT) (RGC)

Growth & Income Stock Strategist, Todd Bunton, highlights Mattel (MAT) and Regal Entertainment (RGC) on October 31, 2013.

Taking Stock of Q3 Earnings Season

While earnings growth is still anemic, it has been better in Q3 than the last few reporting cycles.

Earnings HQ

Today's Noteworthy Earnings Before the Bell:   ››  DISHNRGLFLDHIROC

Today's Noteworthy Earnings After the Bell:   ››  MGNXMWECPASINAFI

Get the First Calendar Made for Traders.

Visit the Zacks Earnings Calendar

Recent Earnings Winners

Company Symbol Reported Surprise %Price Chg
ARKANSAS BEST CP ABFS Nov 11 +0.54% +15.36%
CTI IND CP CTIB Nov 11 +0.07% +10.23%
CHINA YUCHAI INTL LTD CYD Nov 11 +0.46% +8.44%
ENZYMOTEC LTD ORD ENZY Nov 11 +0.13% +6.21%
NAPCO SECURITY TECH INC NSSC Nov 11 +0.01% +3.95%

See All »

Best Earnings ESP Stocks  

Company Symbol Consensus
Est.
Most
Accurate Est.
Reports Zacks Rank ESP
CIA SIDERUR-ADR SID 0.03 0.08 Nov 12 1 +166.67
BEST BUY BBY 0.11 0.13 Nov 19 1 +18.18
TAG OIL LTD T.TAO 0.06 0.08 Nov 21 1 +33.33
NRG YIELD INC-A NYLD 0.37 0.93 Nov 12 1 +151.35
DISH NETWORK CP DISH 0.42 0.44 Nov 12 2 +4.76
Don't trade these stocks until you have read the Zacks ESP Guide

Sponsor

Only Zacks' Hottest Trades. Only $5.

Others pay thousands of dollars to see such privileged, sensitive information. But starting now, you can receive a hand selection of the Best of Our Best, just 2-3 buy recommendations each week at a tiny fraction of their worth.

These trades trounce the market in both win rate and performance. They also cost less than any other Zacks' service. Small wonder they have become by far our most popular.

Find out about these "Must Buys".


Manage Your Newsletter Subscriptions

Update Preferences         Update Your Profile         Unsubscribe All         Feedback         Send to a Friend
 

This free resource is being sent by Zacks.com to our subscribers. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.

All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, brokerage, market making or asset management activities of any securities. Visit www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Emails

If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com.

Zacks Investment Research, Inc.
111 N. Canal St., Suite 1101
Chicago, Illinois 60606